Artigo de periodico

The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy (2022)

• Authors:
  • Lima, Keli
  • Martins, Diego Antonio Pereira
  • Miranda, Lívia Bassani Lins De
  • Silva, Juan Luiz Coelho
  • Leandro, Giovana da Silva
  • Weinhäuser, Isabel
  • Cavaglieri, Rita de Cássia
  • Leal, Aline de Medeiros
  • Silva, Wellington Fernandes da
  • Lange, Ana Paula Alencar de Lima
  • Velloso, Elvira Deolinda Rodrigues Pereira
  • Rego, Eduardo Magalhães
  • Griessinger, Emmanuel
  • Hilberink, Jacobien R.
  • Ammatuna, Emanuele
  • Huls, Gerwin
  • Schuringa, Jan Jacob
  • Machado Neto, João Agostinho
• USP affiliated authors: VELLOSO, ELVIRA DEOLINDA RODRIGUES PEREIRA - FM ; REGO, EDUARDO MAGALHÃES - FM ; MACHADO NETO, JOÃO AGOSTINHO - ICB ; LIMA, KELI CRISTINA DE - FM ; MARTINS, DIEGO ANTONIO PEREIRA - FMRP ; MIRANDA, LÍVIA BASSANI LINS DE - ICB ; LEANDRO, GIOVANA DA SILVA - ICB ; WEINHÄUSER, ISABEL - FMRP
• Unidades: FM; ICB; FMRP
• DOI: 10.1038/s41408-022-00747-w
• Subjects: FARMACOLOGIA; LEUCEMIA MIELOIDE AGUDA; HOMEOSTASE; APOPTOSE; MITOCÔNDRIAS; ESPECTROMETRIA DE MASSAS; CROMATOGRAFIA LÍQUIDA; CÉLULAS-TRONCO
• Agências de fomento:
  • Financiamento FAPESP
  • Financiamento CAPES
• Language: Inglês
• Imprenta:
  • Publisher place: London
  • Date published: 2022
• Source:
  • Título: Blood Cancer Journal
  • ISSN: 2044-5385
  • Volume/Número/Paginação/Ano: v. 12, art. 151, p. 1-11, 2022


Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).

Status:

Artigo publicado em periódico de acesso aberto (Gold Open Access)

Versão do Documento:

Versão publicada (Published version)

Acessar versão aberta:

• PDF de acesso aberto

Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.

---

Download do texto completo

Tipo	Nome	Link
	The PIP4K2 inhibitor THZ-...	Direct link

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  LIMA, Keli et al. The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy. Blood Cancer Journal, v. 12, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41408-022-00747-w. Acesso em: 31 mar. 2026.

• APA

  Lima, K., Martins, D. A. P., Miranda, L. B. L. D., Silva, J. L. C., Leandro, G. da S., Weinhäuser, I., et al. (2022). The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy. Blood Cancer Journal, 12, 1-11. doi:10.1038/s41408-022-00747-w

• NLM

  Lima K, Martins DAP, Miranda LBLD, Silva JLC, Leandro G da S, Weinhäuser I, Cavaglieri R de C, Leal A de M, Silva WF da, Lange APA de L, Velloso EDRP, Rego EM, Griessinger E, Hilberink JR, Ammatuna E, Huls G, Schuringa JJ, Machado Neto JA. The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy [Internet]. Blood Cancer Journal. 2022 ; 12 1-11.[citado 2026 mar. 31 ] Available from: https://doi.org/10.1038/s41408-022-00747-w

• Vancouver

  Lima K, Martins DAP, Miranda LBLD, Silva JLC, Leandro G da S, Weinhäuser I, Cavaglieri R de C, Leal A de M, Silva WF da, Lange APA de L, Velloso EDRP, Rego EM, Griessinger E, Hilberink JR, Ammatuna E, Huls G, Schuringa JJ, Machado Neto JA. The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy [Internet]. Blood Cancer Journal. 2022 ; 12 1-11.[citado 2026 mar. 31 ] Available from: https://doi.org/10.1038/s41408-022-00747-w

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Targeting PIP4K2 lipid kinases through Thz-P1-2 reveals vulnerabilities related to mitochondrial homeostasis and autophagy in acute leukemia
• Pharmacological PIP4K2 inhibition disrupts mitochondrial homeostasis and autophagy in acute leukemia
• Association of KLOTHO polymorphisms with clinical complications of sickle cell anemia
• NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells
• Tumor associated macrophages promoted fatal patient derived acute promyelocytic leukemia in vivo
• Metabolic adaptation and multidrug resistance in FLT3 inhibitor resistant acute myeloid leukemia
• NT157 exhibits antineoplastic effects by targeting IRS and STAT3/5 signaling in multiple myeloma
• Assessing the genetic profile of cytochrome P450 and glutathione S-transferases of patients diagnosed with acute myeloid leukemia
• Synthesis and evaluation of 2-substituted quinazolin-4(3H)-ones as potential antileukemic agents
• In Silico, in vitro, and in vivo studies of a 2-substituted quinazolin-4(3H)-one in T-cell acute lymphoblastic leukemia